Sinopia Biosciences vs Transcripta Bio
Sinopia Biosciences vs Transcripta Bio, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Sinopia Biosciences is on 54/100 and Transcripta Bio on 54/100.
Where each one leads
Sinopia Biosciences
Leads on none of the measures we hold for both companies.
Transcripta Bio
- agent readiness: 49/100 against 40/100
- domain rating: 37/100 against 10/100
- funding raised: $24.0M against $2.2M
At a glance
| Measure | Sinopia Biosciences | Transcripta Bio |
|---|---|---|
| What it is | Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform. | AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development. |
| Category | Biotechnology, Drug Discovery, Oncology, Biotech | Biotechnology, Artificial Intelligence, Drug Discovery, Neurology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2023 |
| Headquarters | San Diego, USA | Palo Alto, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Sinopia Biosciences | Transcripta Bio |
|---|---|---|
| Total funding | $2.2M | $24.0M |
| Latest round | Grant | Series A |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Sinopia Biosciences | Transcripta Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 54/100 |
| Traction | 32/100 | 37/100 |
| Team | 70/100 | 50/100 |
| Search visibility | 15/100 | 17/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (49/100) |
| Domain ratingLink authority, 0-100 | 10/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Sinopia Biosciences | Transcripta Bio |
|---|---|---|
| Frameworks | Not detected | Next.js, Tailwind CSS |
| Analytics | Not detected | Google Analytics 4 |
What users say
| Measure | Sinopia Biosciences | Transcripta Bio |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 1 thread |
“Transcripta Bio Wins the Genomics Category 🧬💻. Transcripta Bio took home the trophy for Genomics, and for good reason. They are bridging the gap between massive transcriptomic data and actual drug candidates.”r/AIDiscoveryAward
Sinopia Biosciences vs Transcripta Bio: common questions
Which is better, Sinopia Biosciences or Transcripta Bio?
Both score the same on our 0-100 rating, so the choice comes down to the 16 data points in the tables above rather than overall company strength.
How do Sinopia Biosciences and Transcripta Bio compare on the numbers?
Transcripta Bio leads on agent readiness (49/100 against 40/100), domain rating (37/100 against 10/100), funding raised ($24.0M against $2.2M).
What do real users say about Sinopia Biosciences and Transcripta Bio?
Transcripta Bio: 1 positive and 0 negative mentions across 1 Reddit threads we track, mostly in r/AIDiscoveryAward.
Read the full Sinopia Biosciences review and pricing or the Transcripta Bio review and pricing. You can also browse other Sinopia Biosciences alternatives we track.